330 related articles for article (PubMed ID: 6502519)
1. Phenobarbital in the genetically obese Zucker rat. II. In vivo and in vitro assessments of microsomal enzyme induction.
Brouwer KL; Kostenbauder HB; McNamara PJ; Blouin RA
J Pharmacol Exp Ther; 1984 Dec; 231(3):654-9. PubMed ID: 6502519
[TBL] [Abstract][Full Text] [Related]
2. Phenobarbital in the genetically obese Zucker rat. I. Pharmacokinetics after acute and chronic administration.
Brouwer KL; Kostenbauder HB; McNamara PJ; Blouin RA
J Pharmacol Exp Ther; 1984 Dec; 231(3):649-53. PubMed ID: 6502518
[TBL] [Abstract][Full Text] [Related]
3. Phenobarbital induction and acetaminophen hepatotoxicity: resistance in the obese Zucker rodent.
Blouin RA; Dickson P; McNamara PJ; Cibull M; McClain C
J Pharmacol Exp Ther; 1987 Nov; 243(2):565-70. PubMed ID: 3681696
[TBL] [Abstract][Full Text] [Related]
4. Effect of genetic obesity and phenobarbital treatment on the hepatic conjugation pathways.
Chaudhary IP; Tuntaterdtum S; McNamara PJ; Robertson LW; Blouin RA
J Pharmacol Exp Ther; 1993 Jun; 265(3):1333-8. PubMed ID: 8510012
[TBL] [Abstract][Full Text] [Related]
5. Differences in the pharmacokinetics of peroxisome proliferator-activated receptor agonists in genetically obese Zucker and sprague-dawley rats: implications of decreased glucuronidation in obese Zucker rats.
Kim MS; Wang S; Shen Z; Kochansky CJ; Strauss JR; Franklin RB; Vincent SH
Drug Metab Dispos; 2004 Sep; 32(9):909-14. PubMed ID: 15319330
[TBL] [Abstract][Full Text] [Related]
6. Acetaminophen hepatotoxicity: influence of phenobarbital and beta-naphthoflavone treatment in obese and lean Zucker rats.
Tuntaterdtum S; Chaudhary IP; Cibull M; Robertson LW; Blouin RA
Toxicol Appl Pharmacol; 1993 Dec; 123(2):219-25. PubMed ID: 8248929
[TBL] [Abstract][Full Text] [Related]
7. Cytochrome P450 2B enzyme induction defect after 2,2',4,4',5,5'-hexachlorobiphenyl treatment in the fa/fa Zucker rat.
Zannikos PN; Bandyopadhyay AM; Robertson LW; Blouin RA
J Pharmacol Exp Ther; 1994 Mar; 268(3):1565-70. PubMed ID: 8138968
[TBL] [Abstract][Full Text] [Related]
8. Cytochrome P450 2B enzyme (CYP2B) induction defect following phenobarbital treatment in the fa/fa Zucker rat: molecular characterization.
Blouin RA; Bandyopadhyay AM; Chaudhary I; Robertson LW; Gemzik B; Parkinson A
Arch Biochem Biophys; 1993 Jun; 303(2):313-20. PubMed ID: 8512318
[TBL] [Abstract][Full Text] [Related]
9. Acitretin elimination in Sprague-Dawley rats pretreated with phenobarbital or beta-naphthoflavone.
Small DS; McNamara PJ
Drug Metab Dispos; 1995 Apr; 23(4):465-72. PubMed ID: 7600913
[TBL] [Abstract][Full Text] [Related]
10. Hepatic cytochrome P-450 and in vitro drug metabolism in an overfed rat model of obesity.
Matsumoto RM; Jusko WJ; Corcoran GB
Drug Nutr Interact; 1988; 5(4):236-47. PubMed ID: 3149237
[TBL] [Abstract][Full Text] [Related]
11. Effect of nutritional obesity on the induction of CYP2B enzymes following phenobarbital treatment.
Zannikos PN; Bandyopadhyay AM; Robertson LW; Blouin RA
Drug Metab Dispos; 1993; 21(5):782-7. PubMed ID: 7902236
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo oxidative biotransformation in the West-African dwarf goat (Caprus hircus aegagrus): substrate activities and effects of inducers.
Zweers-Zeilmaker WM; Batzias J; Maas RF; Horbach GJ; van Miert AS; Witkamp RF
Xenobiotica; 1996 Nov; 26(11):1131-41. PubMed ID: 8948089
[TBL] [Abstract][Full Text] [Related]
13. N-benzylimidazole, a high magnitude inducer of rat hepatic cytochrome P-450 exhibiting both polycyclic aromatic hydrocarbon- and phenobarbital-type induction of phase I and phase II drug-metabolizing enzymes.
Papac DI; Franklin MR
Drug Metab Dispos; 1988; 16(2):259-64. PubMed ID: 2898344
[TBL] [Abstract][Full Text] [Related]
14. Interactions between folate metabolism, phenytoin metabolism, and liver microsomal cytochrome P450.
Billings RE
Drug Nutr Interact; 1984; 3(1):21-32. PubMed ID: 6510238
[TBL] [Abstract][Full Text] [Related]
15. Effect of phenobarbital and spironolactone treatment on the oxidative metabolism of antipyrine by rat liver microsomes.
Szakács T; Veres Z; Vereczkey L
Pol J Pharmacol; 2001; 53(1):11-9. PubMed ID: 11785906
[TBL] [Abstract][Full Text] [Related]
16. Kinetics of drug metabolism in rat liver slices: IV. Comparison of ethoxycoumarin clearance by liver slices, isolated hepatocytes, and hepatic microsomes from rats pretreated with known modifiers of cytochrome P-450 activity.
Carlile DJ; Hakooz N; Houston JB
Drug Metab Dispos; 1999 Apr; 27(4):526-32. PubMed ID: 10101148
[TBL] [Abstract][Full Text] [Related]
17. Correlation between antipyrine clearance and cytochrome P-450 level after phenobarbital induction in rat.
Chang SL; Nelson SD; Levy RH
Drug Metab Dispos; 1984; 12(1):139-41. PubMed ID: 6141905
[No Abstract] [Full Text] [Related]
18. [Activity of the liver monooxygenase system after induction with phenobarbital in the early neonatal period].
Guliaeva LF; Mishin VM
Vopr Med Khim; 1985; 31(5):49-53. PubMed ID: 3937330
[TBL] [Abstract][Full Text] [Related]
19. The effect of tryptophan on the phenobarbital-mediated induction of cytochrome P-450 in rat liver. The role of tryptophan 2,3-dioxygenase.
Kaliman PA; Manandhar SP
Biomed Sci; 1991; 2(3):232-8. PubMed ID: 1751755
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and dynamics of (+/-)-verapamil in lean and obese Zucker rats.
Todd EL; Abernethy DR
J Pharmacol Exp Ther; 1986 Aug; 238(2):642-7. PubMed ID: 3735134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
